Nephros opened higher at $3.27, compared with its previous close of $3.07. In the last trading session, the stock traded between $3.09 and $3.43. It showed an upward intraday trend.
An investment of $100 made 5 years ago in Nephros is now worth
$ 43.03
Resulting in a loss of
$ 56.97 (56.97%)
Note: Past profits do not guarantee future returns.
Rating from 2 Analysts
Today's Change
+$0.22 (+7.23%)
Day High
$3.43
Day Low
$3.09
Day Open
$3.27
Prev Close
$3.07
Volume
1,02,112
1W Return
2.46%
1M Return
-7.27%
3M Return
-23.97%
6M Return
11.59%
1Y Return
-23.97%
Market Cap ($ Mn)
36
PE Ratio
30.20
PB Ratio
4.11
PEG Ratio
1.96
ROE
12.52%
ROCE
10.26%
EPS (TTM)
$0.05
1 Week
2.46%
1 Month
-7.27%
3 Months
-23.97%
6 Months
11.59%
9 Months
-18.51%
Nephros Q2FY26 Results: Net profit rises 400% YoY to $1.2 million
Revenue hit record $6 million in Q2 2026, up 36% YoY and 15% sequentially. Net income surged over 400% to $1.2 million, aided by $600,000 tariff refund. Service revenue nearly tripled as customers adopt installation and replacement plans. Company remains debt-free with $4.7 million cash as of June 30, 2026. New PFAS and nanoplastic products have not yet gained significant traction.
1mo agoNephros Q2 Results: Second quarter 2026 earnings scheduled for August 06
Nephros, Inc. will file its second quarter 2026 financial results on August 06, 2026, after market close. The company will host a conference call at 4:30pm ET to discuss the results. A replay will be available until August 13, 2026, with access code 3951894.
3mo agoNephros CEO to present at Maxim Group virtual conference
Nephros CEO Robert Banks will present at Maxim Group's Health, Wellness & Longevity virtual conference on July 22, 2026, at 10:00 a.m. ET. The event will focus on consumer wellness trends, scientific innovation, and regulatory challenges in the health sector. Institutional investors can attend via digital.maximgrp.com.
3mo agoNephros added to Russell Microcap Index after 2026 reconstitution
Nephros, Inc. has been added to the Russell Microcap Index following the 2026 annual reconstitution. The inclusion became effective after the US market closed on June 26, 2026, and lasts for one year.
4mo agoNephros to host virtual investor event on July 16
Nephros, Inc. announced a virtual investor event on July 16, 2026, to discuss its water safety model and growth strategies. The event will feature insights from field leaders and the Nephros Water Institute, followed by a live Q&A with leadership.
4mo agoNephros tech targets microplastics after EPA list update
Nephros, Inc. has highlighted its ultrafiltration technology's ability to capture microplastics and nanoplastics, aligning with the U.S. EPA's April 2026 decision to list microplastics as a priority contaminant. The company's filters, with 5-nanometer pores, address a gap in conventional filtration that often misses nanoplastics. CEO Robert Banks emphasized the technology's role in differentiating Nephros in the healthcare and water quality markets.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 5 years ago in Nephros is now worth
$ 43.03
Resulting in a loss of
$ 56.97 (56.97%)
Note: Past profits do not guarantee future returns.
